Diffusion of cefepime into cancellous and cortical bone tissue

Journal of Chemotherapy

Volumn 15, Issue 2, 2003, Pages 134-138

  Breilh, Dominique ^a   Boselli, E ^b   Bel, J C ^c   Chassard, D ^b   Saux, M C ^a   Allaouchiche, B ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Antibiotics; Bone; Cefepime; Diffusion; Surgical prophylaxis

Indexed keywords

CEFEPIME;

AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE INFECTION; CANCELLOUS BONE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; CREATININE CLEARANCE; DRUG DIFFUSION; DRUG EFFICACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; OPEN STUDY; PLASMA; SAMPLING; TOTAL HIP PROSTHESIS;

EID: 0038627983     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.2.134     Document Type: Article

References (17)

1. Boselli E, Allaouchiche B. Diffusion osseuse des antibiotiques. Presse Med 1999; 28: 2265-2276.
2. Lim VK, Halijah MY. A comparative study of the in-vitro activity of cefepime and other cephalosporins. Malays J Pathol 1993; 15: 65-68.
3. Sanders CC. Cefepime: the next generation? Clin Infect Dis 1993; 17: 369-379.
4. Wynd MA, Paladino JA. Cefepime: a fourth-generation parenteral cephalosporin. Ann Pharmacother 1996; 30: 1414-1424.
5. Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Cefepime: a new fourth-generation cephalosporin. Am J Hosp Pharm 1994; 51: 463-477; quiz 541-462.
6. Okamoto MP, Nakahiro RK, Chin A, Bedikian A. Cefepime clinical pharmacokinetics. Clin Pharmacokinet 1993; 25: 88-102.
7. Breilh D, Lavallee C, Fratta A, Ducint D, Cony-Makhoul P, Saux MC. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction. J Chromatogr B Biomed Sci Appl 1999; 734: 121-127.
8. Lovering AM, Perez J, Bowker KE, Reeves DS, MacGowan AP, Bannister G. A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement. J Antimicrob Chemother 1997; 40: 99-104.
9. Ellner PD, Neu HC. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA 1981; 246: 1575-1578.
10. Petitjean O, Jehl F, Tod M. Pénétration tissulaire des antibiotiques. In: Martin C, Gouin F, eds. Infections et antibiothérapie en réanimation, aux urgences et en chirurgie. Rueil-Malmaison: Arnette. 2001: 1029-1103.
11. Bouza E, Muñoz P. Micro-organisms responsible for osteo-articular infections. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 21-35.
12. Hardin TC, Jennings TS. Cefepime. Pharmacotherapy 1994; 14: 657-668.
13. Jauregui L, Matzke D, Scott M, Minns P, Hageage G. Cefepime as treatment for osteomyelitis and other severe bacterial infections. J Antimicrob Chemother 1993; 32 Suppl B: 141-149.
14. Wittmann DH, Schassand HH, Faitag V. Pharmacokinetics studies and results of a clinical trial with cefotaxime (HR-756). In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious diseases. Washington, DC: American Society for Microbiology. 1980: 114-116.
15. Braga PC, Pozzato C, Cedrini C, et al. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue. Clin Ther 1982; 5: 69-78.
16. Soudry B, Sirot J, Lopitaux R, Dumont C, Delisle JJ, Parenton M. Diffusion de la ceftriaxone dans le tissu osseux humain. Pathol Biol (Paris) 1986; 34: 859-862.
17. Leigh DA, Griggs J, Tighe CM, et al. Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty. J Antimicrob Chemother 1985; 16: 637-642.